Serrano, C., Wang, Y., Mariño-Enríquez, A., Lee, J., Ravegnini, G., Morgan, J. A., . . . Fletcher, J. A. (2015). KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation. J Clin Oncol.
Citação norma ChicagoSerrano, César, et al. "KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation." J Clin Oncol 2015.
Citação norma MLASerrano, César, et al. "KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation." J Clin Oncol 2015.